secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOROX CO /DE/ (CLX)
CIK:        0000021076
Form:       8-K
Filed at:   2026-02-03T23:59:59+00:00
Accession:  0000021076-26-000008
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clorox Q2 FY2026 sales down 1% to $1.67B, EPS $1.29, reaffirms outlook
----------------------------------------------------------------------

- Net sales $1.67B (-1% YoY); organic sales -1%; gross margin 43.2% (-60 bps).
- Diluted EPS $1.29 (-16% YoY); adjusted EPS $1.39 (-10% YoY).
- YTD operating cash flow $404M (+1%); free cash flow $326M (10.5% of sales).
- Segment: Health & Wellness +2%, Household -6%, Lifestyle -5%, International +7%.
- CEO Linda Rendle reaffirms FY2026 outlook; cites recently announced GOJO acquisition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/21076/000002107626000008/0000021076-26-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/21076/000002107626000008/clx-20260203.htm
  HTML page:      https://secwatch.observer/filing/0000021076-26-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer